Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
Price was the key driver for the period
Subscribe To Our Newsletter & Stay Updated
